This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Scopolamine Hydrobromide Injection (2016-01-22)
- Starting date:
- January 22, 2016
- Posting date:
- February 16, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-56968
Affected products
Scopolamine Hydrobromide Injection
Reason
Out of specification result for potency during shelf life testing.
Depth of distribution
Wholesalers and hospitals across Canada
Affected products
Scopolamine Hydrobromide Injection
DIN, NPN, DIN-HIM
DIN 00541869
Dosage form
Sterile solution for injection
Strength
0.4 mg/ml
Lot or serial number
290628E01
Companies
- Recalling Firm
-
Hospira Healthcare Corporation, a Pfizer Company
2600 Alfred-Nobel Blvd. Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
- Marketing Authorization Holder
-
Hospira Healthcare Corporation, a Pfizer Company
2600 Alfred-Nobel Blvd. Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA